Communicating for the Safe Use of Medicines: Progress and Directions for the 2020s Promoted by the Special Interest Group of the International Society of Pharmacovigilance
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:46 |
|---|---|
| Enthalten in: |
Drug safety - 46(2023), 6 vom: 23. Mai, Seite 517-532 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Bahri, Priya [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| Anmerkungen: |
© The Author(s), under exclusive licence to Springer Nature Switzerland AG 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. |
|---|
| doi: |
10.1007/s40264-023-01285-5 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR05166044X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR05166044X | ||
| 003 | DE-627 | ||
| 005 | 20230527064758.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230527s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s40264-023-01285-5 |2 doi | |
| 035 | |a (DE-627)SPR05166044X | ||
| 035 | |a (SPR)s40264-023-01285-5-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Bahri, Priya |e verfasserin |0 (orcid)0000-0002-7798-6117 |4 aut | |
| 245 | 1 | 0 | |a Communicating for the Safe Use of Medicines: Progress and Directions for the 2020s Promoted by the Special Interest Group of the International Society of Pharmacovigilance |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © The Author(s), under exclusive licence to Springer Nature Switzerland AG 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. | ||
| 700 | 1 | |a Bowring, Geoffrey |4 aut | |
| 700 | 1 | |a Edwards, Brian D. |4 aut | |
| 700 | 1 | |a Anton, Christopher |4 aut | |
| 700 | 1 | |a Aronson, Jeffrey K. |4 aut | |
| 700 | 1 | |a Caro-Rojas, Angela |4 aut | |
| 700 | 1 | |a Hugman, Bruce P. J. |4 aut | |
| 700 | 1 | |a Mol, Peter G. |4 aut | |
| 700 | 1 | |a Trifirò, Gianluca |4 aut | |
| 700 | 1 | |a Ilic, Katarina |4 aut | |
| 700 | 1 | |a Daghfous, Riadh |4 aut | |
| 700 | 1 | |a Fermont, Irene |4 aut | |
| 700 | 1 | |a Furlan, Giovanni |4 aut | |
| 700 | 1 | |a Gaissmaier, Wolfgang |4 aut | |
| 700 | 1 | |a Geer, Mohammad Ishaq |4 aut | |
| 700 | 1 | |a Hartigan-Go, Kenneth Y. |4 aut | |
| 700 | 1 | |a Houÿez, François |4 aut | |
| 700 | 1 | |a Neth, Hansjörg |4 aut | |
| 700 | 1 | |a Norgela, Gediminas |4 aut | |
| 700 | 1 | |a Oppamayun, Yaowares |4 aut | |
| 700 | 1 | |a Raynor, D. K. Theo |4 aut | |
| 700 | 1 | |a Bouhlel, Mehdi |4 aut | |
| 700 | 1 | |a Santoro, Federica |4 aut | |
| 700 | 1 | |a Sultana, Janet |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Drug safety |d Berlin [u.a.] : Springer, 1990 |g 46(2023), 6 vom: 23. Mai, Seite 517-532 |w (DE-627)SPR033090823 |w (DE-600)2023894-0 |x 1179-1942 |7 nnns |
| 773 | 1 | 8 | |g volume:46 |g year:2023 |g number:6 |g day:23 |g month:05 |g pages:517-532 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s40264-023-01285-5 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 951 | |a AR | ||
| 952 | |d 46 |j 2023 |e 6 |b 23 |c 05 |h 517-532 | ||